Synact Pharma ApS

Danemark

Commandez votre montre hebdomadaire Synact Pharma ApS
Quantité totale PI 24
Rang # Quantité totale PI 63 891
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 698

Brevets

Marques

10 0
5 0
9 0
0
 
Dernier brevet 2025 - Combination treatment of arthrit...
Premier brevet 2007 - Phenyl pyrrole aminoguanidine de...

Derniers inventions, produits et services

2025 Invention Combination treatment of arthritic disease. The present invention relates to a composition compr...
2024 Invention Treatment of subpopulation of patients with rheumatoid arthritis. Provided is a therapy comprisin...
Invention Polymorphs of phenyl pyrrole aminoguandium salts. The present disclosure relates to crystalline f...
2023 Invention Polymorph of phenyl pyrrole hydrazine carboximidamide compound. The present disclosure relates to...
Invention Resomelagon and its derivatives for the treatment of cardiovascular disease, hypertension and ath...
2022 Invention Phenyl pyrrole aminoguanidine salts and formulations. The disclosure relates to oral formulation...
Invention Treatment of rheumatoid arthritis. Provided is a combination therapy comprising optimised dosage...
Invention Treatment of rheumatoid arthritis. Provided is a combination therapy comprising optimised dosages...
Invention Salts of phenyl pyrrole aminoguanidine and polymorphs of phenyl pyrrole aminoguanidinium salts. T...
Invention Phenyl pyrrole aminoguanidine salts and formulations. The disclosure relates to oral formulations...
Invention Salts of phenyl pyrrole aminoguanidine and polymorphs of phenyl pyrrole aminoguanidinium salts. N...
2021 Invention Treatment of symptomatic viral diseases. Provided is a composition comprising a phenyl pyrrole a...
Invention Treatment of symptomatic viral diseases. Provided is a composition comprising a phenyl pyrrole am...
2020 Invention Treatment of proteinuria. Provided is a composition comprising a phenyl pyrrole aminoguanidine d...
Invention Combination treatment of arthritic disease. The present invention relates to a composition compri...
Invention Combination treatment of arthritic disease. ENtranstrans-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-al...
Invention Combination therapy using ap1189 andmethotrexate for treatment of arthritic disease. The present ...
2019 Invention Treatment of proteinuria with n-phenylpyrrolyl iminoguanidines. Provided is a composition compris...
Invention Treatment of proteinuria. Provided is a composition comprising a phenyl pyrrole aminoguanidine de...
2007 Invention Phenyl pyrrole aminoguanidine derivatives. The present invention relates to phenyl pyrrole aminog...